Table 3.
Existing scaffolding approaches, insufficiencies and future directions for IVD tissue engineering
Stage of disc degeneration | Existing scaffolding approaches | Insufficiencies | Proposed future directions |
---|---|---|---|
Early degeneration | Injection of cells with and without hydrogel carriers (Approach 4) | Poor engraftment and viability | Improved viscosity and stiffness of carriers to reduce leakage and extrusion; welding or bioglue techniques to prevent leakage and extrusion |
Mid-stage degeneration | Implantation of cell-seeded pre-made porous scaffolds (Approach 1) Implantation of cell-seeded decellularized ECM (Approach 2) Injection of cells with hydrogel carriers to replace loss in matrix (Approach 4) | Lack of in vivo model; extrusion of implants under loading | Welding or bioglue techniques to prevent leakage and extrusion; technologies to enhance the mechanical properties of scaffolds without compromising the cell viability |
Late degeneration | Allogenic whole disc for total disc replacement; (Approach 2) Building interface between multiple tissue components | Short-term maintenance of disc height and hydration; degeneration of allograft in long term; lack of remodeling cells | Better graft preservation technologies to maintain matrix composition; scaffolds providing appropriate microenvironment for cells to remodel upon mechanical stimulationImprovement of proteoglycan retention in scaffolds for nucleus replacements; improvement of scaffold mechanical properties for stable annulus replacements; combinatory approach for IVD scaffolding; engineering of stable tissue interfaces |